Company Overview

Biocogniv develops an AI-powered diagnostic platform that predicts sepsis-related mortality and ICU admission in emergency departments, earning FDA Breakthrough Device Designation for its technology. The Burlington, VT-based company, backed by Y Combinator (W20) and investors including Breyer Capital, has raised $17.08M in total funding and generated $2.6M in revenue in 2024. Founded in 2019, Biocogniv operates with a 13-person team delivering critical sepsis prediction capabilities to healthcare providers.

Revenue
$17.08M
Loading News...
Loading Timeline...
Loading Culture...
Loading Leadership...

Open Positions

Reddit Discussions

Loading Competitive Intelligence...

Key Differentiators

Emerging Innovator

Biocogniv is an emerging player bringing innovative solutions to the Healthcare market.

Frequently Asked Questions

AI Visibility Rankings

How Biocogniv performs in AI search results

AI Rank
?
Track your position
Platforms
5
ChatGPT, Gemini, Claude...
Visibility
?
Your mention rate
Premium Feature

Unlock AI Visibility Tracking for Biocogniv

See exactly how Biocogniv ranks across ChatGPT, Gemini, Perplexity, Claude, and Grok. Get actionable insights to improve your AI search performance.

Real-time Rankings
Track your position daily
Competitive Intel
See how you compare
Platform Breakdown
Per-AI performance
Actionable Insights
Optimize your visibility
Start Tracking for Free

Join 1,000+ brands · Free 7-day trial · No credit card required

Want to improve your AI visibility? Track performance across all major AI platforms.
Compare with Other Brands

Compare with Other Brands

See how Biocogniv stacks up against competitors with our detailed comparison tool.

Start Comparison